ABPO

PINK Abpro Holdings, Inc.
Oct 23, 2026 · 7:21 AM ET EOD Market Closed

$0.4005 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.4005, $0.0245 below the day’s high of $0.4250

YTD change
+146.16%
vs 20-day SMA
+1.06%
vs 200-day SMA
N/A

Price ranges

Previous day
$0.3900 $0.4250
open $0.3900 close $0.4005
+$0.0105 (+2.69%)
Today
$0.3900 $0.4250
$0.4005
Past week
$0.3555 $0.4081
from $0.3689 now $0.4005
+$0.0317 (+8.58%)
Past month
$0.3500 $0.4300
from $0.3500 now $0.4005
+$0.0505 (+14.43%)
This year
$0.0866 $0.4980
from $0.1627 now $0.4005
+$0.2378 (+146.16%)

Price & Performance

+0.26 (+180.86%) / 6M

$0.1179$0.2261$0.3342$0.4424Apr 23Jul 22Oct 21

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 19.6% away from all-time highs of $0.4980
  • ABPO is up 146% since the beginning of the year
  • ABPO is up 146% over the past 12 months
  • ABPO is up 14% over the past 1 month
  • 0% of all ABPO investors are betting against ABPO

ABPO reads very good: the 12-month move is +146.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.1594
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $-1216540.0
Beta 0.48

Balance sheet & scale

Income$2.0K
RevenueN/A
Cash$4.2M
Debt$171.0
Income / Debt 11.76×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Market cap $2.4M

Abpro Holdings, Inc. is a biotechnology company focused on the development of novel antibodies using discovery and engineering platforms for immuno-oncology, ophthalmology, and infectious disease. The company was founded in 2004 and is headquartered in Burlington, MA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.